Every article, report, and earnings note where COO appears.
The Cooper Companies, Inc. (COO) slumps after fiscal Q3 earnings, updated guidance, and a completed strategic review disappointed investors. A small EPS miss, weaker CooperVision revenue, and reduced takeover hopes sparked the sharp extended-hours drop.
The Cooper Companies, Inc. (COO) slumps after hours after fiscal Q3 results showed an EPS beat but a revenue miss and softer Q4 guidance. Investors are reacting to slowing sales growth and a premium valuation, which could keep pressure on the stock if the decline holds into regular trading.
Cooper Companies posted 8% revenue growth and 26% non-GAAP EPS growth in Q2, with premium contact lenses and fertility driving the story. A strategic review at CooperSurgical adds a potential value catalyst, while debt and Asia Pacific weakness keep the risk profile moderate.
The Cooper Companies, Inc. (COO) rises after posting a strong quarterly beat and lifting full-year earnings guidance. Investors responded to solid contact lens demand, improved profitability, and heavier trading volume, signaling renewed confidence in the healthcare stock’s outlook.
Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.
Generate COO ReportCancel anytime